ACE2 and COVID-19: Combining the latter reports with our results, one could speculate that the downregulation of MDM2 could lead to an upregulation of ACE2, subsequently leading to a higher SARS-CoV infection rate, higher tissue damage in the kidney, and an overall poor prognosis in cases of severe COVID-19.